Last 7 days
-4.4%
Last 30 days
-15.5%
Last 90 days
-9.6%
Trailing 12 Months
-2.9%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
HCA | 70.6B | 60.2B | -4.86% | -6.89% | 12.5 | 1.17 | 2.52% | -18.88% |
LH | 19.6B | 14.9B | -11.65% | -18.57% | 15.35 | 1.32 | -7.72% | -46.20% |
DGX | 15.5B | 9.9B | -9.17% | -4.78% | 16.43 | 1.57 | -8.39% | -52.58% |
MID-CAP | ||||||||
UHS | 8.8B | 13.4B | -20.72% | -21.03% | 13 | 0.66 | 5.99% | -31.87% |
DVA | 7.1B | 11.6B | -9.20% | -31.27% | 12.59 | 0.61 | -0.08% | -42.73% |
THC | 6.1B | 19.2B | -9.72% | -38.02% | 6.13 | 0.32 | -1.60% | -32.18% |
EHC | 5.3B | 4.3B | -15.50% | -2.92% | 19.39 | 1.21 | 8.31% | -34.26% |
SGRY | 4.1B | 2.5B | -9.79% | -38.94% | -74.24 | 1.6 | 14.12% | 22.99% |
SEM | 3.3B | 6.3B | -15.00% | 4.69% | 20.58 | 0.52 | 2.08% | -60.47% |
SMALL-CAP | ||||||||
ADUS | 1.6B | 951.1M | -7.28% | 30.41% | 34.53 | 1.67 | 10.02% | 1.99% |
RDNT | 1.3B | 1.4B | 12.22% | 10.36% | 120.12 | 0.89 | 8.74% | -56.93% |
CYH | 724.7M | 12.2B | -1.54% | -55.54% | 15.75 | 0.06 | -1.27% | -80.00% |
BKD | 524.3M | 2.8B | -3.12% | -59.80% | -2.2 | 0.19 | 2.43% | -140.13% |
SSY | 7.5M | 45.8M | -2.78% | -21.05% | -2.54 | 0.16 | 11.66% | -153.83% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 2.2% | 4,349 | 4,254 | 4,175 | 4,114 | 4,015 |
S&GA Expenses | -19.8% | 154 | 192 | 193 | 187 | 170 |
EBITDA | -2.3% | 870 | 891 | 1,101 | 1,053 | - |
EBITDA Margin | -4.4% | 0.20* | 0.21* | 0.19* | 0.20* | - |
Earnings Before Taxes | -1.7% | 451 | 458 | 479 | 566 | 505 |
EBT Margin | -3.8% | 0.10* | 0.11* | 0.11* | 0.12* | - |
Interest Expenses | -1.5% | 176 | 178 | 180 | 161 | 164 |
Net Income | -0.8% | 271 | 273 | 328 | 392 | 412 |
Net Income Margin | -3.0% | 0.06* | 0.06* | 0.06* | 0.08* | - |
Free Cahsflow | 56.3% | 141 | 90.00 | 219 | 231 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 2.9% | 5,637 | 5,476 | 7,082 | 6,944 | 6,865 |
Current Assets | -2.3% | 717 | 734 | 1,032 | 950 | 921 |
Cash Equivalents | -63.5% | 22.00 | 60.00 | 187 | 94.00 | 49.00 |
Goodwill | 1.3% | 1,263 | 1,247 | 2,457 | 2,457 | 1,237 |
Liabilities | 1.2% | 3,775 | 3,728 | 4,538 | 4,452 | 4,466 |
Current Liabilities | -4.8% | 576 | 605 | 835 | 755 | 749 |
Long Term Debt | 0.8% | 2,742 | 2,719 | 3,234 | 3,221 | 3,241 |
Shareholder's Equity | 7.7% | 1,310 | 1,217 | 2,501 | 2,448 | 1,911 |
Retained Earnings | -18.4% | 116 | 142 | - | - | - |
Additional Paid-In Capital | -24.4% | 1,730 | 2,290 | - | - | - |
Shares Outstanding | 0% | 99.00 | 99.00 | 125 | - | - |
Minority Interest | 4.7% | 516 | 493 | 498 | 475 | 446 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | 7.4% | 706 | 657 | 765 | 776 | 716 |
Share Based Compensation | -4.6% | 29.00 | 31.00 | 31.00 | 34.00 | 29.00 |
Cashflow From Investing | 2.2% | -627 | -641 | -591 | -693 | -666 |
Cashflow From Financing | -67.7% | -145 | -86.90 | -56.40 | -223 | -240 |
Dividend Payments | -11.4% | 99.00 | 112 | 112 | 112 | 112 |
Buy Backs | NaN% | 0.00 | 0.00 | - | - | - |
67.7%
31.9%
0%
Y-axis is the maximum loss one would have experienced if Encompass Health was unfortunately bought at previous high price.
12.0%
11.1%
4.1%
2.2%
FIve years rolling returns for Encompass Health.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | added | 3.03 | 37,494,400 | 140,961,000 | 0.15% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 3.94 | 4,000 | 15,000 | -% |
2023-02-28 | Voya Investment Management LLC | added | 4.51 | 224,997 | 812,997 | -% |
2023-02-24 | SRS Capital Advisors, Inc. | reduced | -13.76 | 634 | 5,634 | -% |
2023-02-22 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | added | 161 | 1,708,000 | 2,403,000 | 0.03% |
2023-02-21 | NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC | reduced | -35.92 | -99,714 | 552,286 | 0.01% |
2023-02-21 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | unchanged | - | 316 | 1,316 | -% |
2023-02-21 | MACQUARIE GROUP LTD | reduced | -15.6 | 4,916,000 | 48,007,000 | 0.06% |
2023-02-21 | Ruedi Wealth Management, Inc. | new | - | 12,082 | 12,082 | 0.01% |
2023-02-17 | TRUIST FINANCIAL CORP | reduced | -1.14 | 3,796,510 | 16,153,500 | 0.03% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | vanguard group inc | 9.77% | 9,749,441 | SC 13G/A | |
Feb 06, 2023 | wellington management group llp | 9.58% | 9,558,849 | SC 13G/A | |
Jan 30, 2023 | blackrock inc. | 11.3% | 11,232,620 | SC 13G/A | |
Jan 30, 2023 | blackrock inc. | 11.3% | 11,232,620 | SC 13G/A | |
Feb 10, 2022 | vanguard group inc | 9.46% | 9,414,569 | SC 13G/A | |
Feb 04, 2022 | wellington management group llp | 10.58% | 10,524,661 | SC 13G/A | |
Jan 27, 2022 | blackrock inc. | 10.7% | 10,643,463 | SC 13G/A | |
Jan 25, 2022 | blackrock inc. | 10.7% | 10,643,463 | SC 13G/A | |
Feb 11, 2021 | william blair investment management, llc | 4.70% | 4,666,500 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 9.05% | 8,998,232 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | - - | - - | - - | - - | - - |
Current Inflation | 23.57 -55.50% | 35.05 -33.83% | 50.03 -5.55% | 61.65 16.39% | 72.40 36.68% |
Very High Inflation | - - | - - | - - | - - | - - |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 14, 2023 | 8-K | Current Report | |
Mar 02, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading | |
Feb 28, 2023 | 4 | Insider Trading | |
Feb 28, 2023 | 4 | Insider Trading | |
Feb 28, 2023 | 4 | Insider Trading | |
Feb 28, 2023 | 4 | Insider Trading | |
Feb 28, 2023 | 4 | Insider Trading | |
Feb 28, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-02-27 | Darby John Patrick | sold (taxes) | -30,652 | 60.22 | -509 | evp, gen counsel & secretary |
2023-02-27 | Tarr Mark J | sold (taxes) | -174,337 | 60.22 | -2,895 | president & ceo |
2023-02-27 | Price Andrew L | sold (taxes) | -24,690 | 60.22 | -410 | chief accounting officer |
2023-02-27 | Charbonneau Elissa Joy | sold (taxes) | -30,471 | 60.22 | -506 | chief medical officer |
2023-02-27 | COLTHARP DOUGLAS E | sold (taxes) | -64,917 | 60.22 | -1,078 | evp & chief financial officer |
2023-02-27 | Fay Edmund | sold (taxes) | -23,064 | 60.22 | -383 | sr. vice pres. and treasurer |
2023-02-24 | COLTHARP DOUGLAS E | sold (taxes) | -50,584 | 60.22 | -840 | evp & chief financial officer |
2023-02-24 | Price Andrew L | sold (taxes) | -19,270 | 60.22 | -320 | chief accounting officer |
2023-02-24 | Fay Edmund | sold (taxes) | -18,005 | 60.22 | -299 | sr. vice pres. and treasurer |
2023-02-24 | Darby John Patrick | sold (taxes) | -23,907 | 60.22 | -397 | evp, gen counsel & secretary |
Consolidated Statements of Comprehensive Income - USD ($) shares in Millions, $ in Millions | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Statement of Comprehensive Income and Income Statement [Abstract] | |||
Net operating revenues | $ 4,348.6 | $ 4,014.9 | $ 3,566.3 |
Operating expenses: | |||
Salaries and benefits | 2,393.3 | 2,127.3 | 1,903.8 |
Other operating expenses | 670.4 | 595.9 | 545.1 |
Occupancy costs | 54.7 | 59.0 | 61.4 |
Supplies | 202.1 | 184.2 | 171.0 |
General and administrative expenses | 154.3 | 169.5 | 151.6 |
Depreciation and amortization | 243.6 | 219.6 | 203.0 |
Government, class action, and related settlements | 0.0 | 0.0 | 2.8 |
Total operating expenses | 3,718.4 | 3,355.5 | 3,038.7 |
Loss on early extinguishment of debt | 1.4 | 1.0 | 2.3 |
Interest expense and amortization of debt discounts and fees | 175.7 | 164.3 | 183.7 |
Other expense (income) | 5.2 | (7.5) | (8.4) |
Equity in net income of nonconsolidated affiliates | (2.9) | (3.4) | (2.9) |
Income from continuing operations before income tax expense | 450.8 | 505.0 | 352.9 |
Provision for income tax expense | 100.1 | 101.9 | 74.7 |
Income from continuing operations | 350.7 | 403.1 | 278.2 |
Income from discontinued operations, net of tax | 15.2 | 114.1 | 90.6 |
Net and comprehensive income | 365.9 | 517.2 | 368.8 |
Net and comprehensive income | 365.9 | 517.2 | 368.8 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (93.6) | (103.2) | (83.3) |
Less: Net income attributable to noncontrolling interests included in discontinued operations | (1.3) | (1.8) | (1.3) |
Less: Net and comprehensive income attributable to noncontrolling interests | (94.9) | (105.0) | (84.6) |
Less: Net and comprehensive income attributable to noncontrolling interests | (94.9) | (105.0) | (84.6) |
Net and comprehensive income attributable to Encompass Health | 271.0 | 412.2 | 284.2 |
Net and comprehensive income attributable to Encompass Health | $ 271.0 | $ 412.2 | $ 284.2 |
Weighted average common shares outstanding: | |||
Basic (in shares) | 99.2 | 99.0 | 98.6 |
Diluted (in shares) | 100.4 | 100.2 | 99.8 |
Basic earnings per share attributable to Encompass Health common shareholders: | |||
Continuing operations (in dollars per share) | $ 2.58 | $ 3.02 | $ 1.97 |
Discontinued operations (in dollars per share) | 0.14 | 1.13 | 0.90 |
Net income (in dollars per share) | 2.72 | 4.15 | 2.87 |
Diluted earnings per share attributable to Encompass Health common shareholders: | |||
Continuing operations (in dollars per share) | 2.56 | 2.99 | 1.96 |
Discontinued operations (in dollars per share) | 0.14 | 1.12 | 0.89 |
Net income (in dollars per share) | $ 2.70 | $ 4.11 | $ 2.85 |
Amounts attributable to Encompass Health: | |||
Income from continuing operations | $ 257.1 | $ 299.9 | $ 194.9 |
Income from discontinued operations, net of tax | 13.9 | 112.3 | 89.3 |
Net and comprehensive income attributable to Encompass Health | $ 271.0 | $ 412.2 | $ 284.2 |
Consolidated Balance Sheets - USD ($) $ in Millions | Dec. 31, 2022 | Dec. 31, 2021 | ||
---|---|---|---|---|
Current assets: | ||||
Cash and cash equivalents | $ 21.8 | $ 49.4 | ||
Restricted cash | 31.6 | 62.5 | ||
Accounts receivable | 536.8 | 515.8 | ||
Prepaid expenses and other current assets | 127.0 | 114.9 | ||
Current assets of discontinued operations | 0.0 | 178.8 | ||
Total current assets | 717.2 | 921.4 | ||
Property and equipment, net | 2,939.2 | 2,581.2 | ||
Operating lease right-of-use assets | 212.5 | 193.7 | ||
Goodwill | 1,263.2 | 1,237.0 | ||
Intangible assets, net | 282.3 | 158.4 | ||
Other long-term assets | 222.0 | 230.0 | ||
Noncurrent assets of discontinued operations | 0.1 | 1,543.2 | ||
Total assets | [1] | 5,636.5 | 6,864.9 | |
Current liabilities: | ||||
Current portion of long-term debt | 25.2 | 37.8 | ||
Current operating lease liabilities | 25.6 | 23.5 | ||
Accounts payable | 132.9 | 134.0 | ||
Accrued payroll | 168.3 | 199.4 | ||
Accrued interest payable | 42.8 | 44.4 | ||
Other current liabilities | 181.0 | 177.3 | ||
Current liabilities of discontinued operations | 0.1 | 132.4 | ||
Total current liabilities | 575.9 | 748.8 | ||
Long-term debt, net of current portion | 2,741.8 | 3,240.5 | ||
Long-term operating lease liabilities | 199.7 | 179.6 | ||
Self-insured risks | 128.5 | 123.8 | ||
Deferred income tax liabilities | 83.0 | 23.3 | ||
Other long-term liabilities | 45.3 | 48.9 | ||
Noncurrent liabilities of discontinued operations | 0.4 | 100.8 | ||
Total liabilities | 3,774.6 | 4,465.7 | ||
Commitments and contingencies | ||||
Redeemable noncontrolling interests | 35.6 | 42.2 | ||
Encompass Health shareholders’ equity: | ||||
Common stock, $.01 par value; 200,000,000 shares authorized; issued: 114,775,056 in 2022; 114,211,057 in 2021 | 1.1 | 1.1 | ||
Capital in excess of par value | 1,730.2 | 2,289.6 | ||
Accumulated income | 115.7 | 141.8 | ||
Treasury stock, at cost (14,992,125 shares in 2022 and 14,719,662 shares in 2021) | (536.7) | (521.2) | ||
Total Encompass Health shareholders’ equity | 1,310.3 | 1,911.3 | ||
Noncontrolling interests | 516.0 | 445.7 | ||
Total shareholders’ equity | 1,826.3 | 2,357.0 | ||
Liabilities and Equity, Total | [1] | $ 5,636.5 | $ 6,864.9 | |
|